<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03640689</url>
  </required_header>
  <id_info>
    <org_study_id>NUIreland1</org_study_id>
    <nct_id>NCT03640689</nct_id>
  </id_info>
  <brief_title>DEep VEin Lesion OPtimisation (DEVELOP) Trial</brief_title>
  <acronym>Develop</acronym>
  <official_title>DEep VEin Lesion OPtimisation (DEVELOP) Trial: A Randomised, Assessor-blinded Feasibility Study of Iliac Vein Intervention for Venous Leg Ulcers</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>National University of Ireland, Galway, Ireland</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>National University of Ireland, Galway, Ireland</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>Yes</is_fda_regulated_device>
    <is_us_export>Yes</is_us_export>
  </oversight_info>
  <brief_summary>
    <textblock>
      This is a prospective, single centre, randomised controlled, feasibility study recruiting
      patients with lower limb venous ulceration and Great Saphenous incompetence. Patients will be
      randomised to undergo either truncal ablation and compression therapy or truncal ablation,
      simultaneous iliac interrogation with intravascular ultrasound and stenting of significant
      (&gt;50%) iliac vein lesions plus compression therapy. The primary endpoints will be ulcer
      healing and procedural safety. Secondary endpoints include time to healing, quality of life
      and clinical scores, ulcer recurrence rates and rates of post-thrombotic syndrome. Follow up
      will be over a five-year period. This feasibility study is designed to include 60 patients.
      Should it be practicable a total of 594 patients would be required to adequately power the
      study to definitively address ulcer-healing rates.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The single main research question for this trial is as follows: in adult patients with venous
      ulceration and great saphenous vein incompetence; does iliac vein assessment with IVUS and
      stenting of significant occlusive disease in addition to superficial great saphenous venous
      ablation and compression compared to superficial venous ablation and compression alone offer
      improved ulcer healing rates at three months following treatment?

      Primary Objective To determine whether superficial venous ablation plus early iliac vein
      interrogation plus endovascular stenting in the presence of significant occlusive disease
      results in improved venous ulcer healing compared to superficial venous ablation plus
      compression therapy alone.

      Secondary Objectives

      1. To determine the relative performance of duplex ultrasound compared to IVUS for the
      prediction of NIVLs 3. To determine the rate of primary or recurrent ulceration up to five
      years following intervention 4. To assess patient quality of life in the short and medium
      term following each mode of intervention
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">July 15, 2019</start_date>
  <completion_date type="Anticipated">September 1, 2024</completion_date>
  <primary_completion_date type="Anticipated">September 1, 2024</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Diagnostic</primary_purpose>
    <masking>Double (Investigator, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Ulcer Healing - Proportion of ulcers healed</measure>
    <time_frame>3-months</time_frame>
    <description>Proportion of ulcers healed</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Iliac Vein Patency on duplex ultrasound</measure>
    <time_frame>6-months</time_frame>
    <description>Patency of the iliac vein on duplex</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Reintervention</measure>
    <time_frame>12-months</time_frame>
    <description>Freedom from re-intervention</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Ulcer healing - Time to ulcer healing</measure>
    <time_frame>In days</time_frame>
    <description>Time to ulcer healing</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Patient Quality of life using the Aberdeen Varicose Vein Questionnaire</measure>
    <time_frame>12-months</time_frame>
    <description>Aberdeen Varicose Vein Questionnaire measured from 0(no effect)-100(severe effect). The higher the score the greater the negative impact on patient quality of life.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Recurrence - Ulcer recurrence</measure>
    <time_frame>12-months</time_frame>
    <description>Ulcer recurrence</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">60</enrollment>
  <condition>Venous Leg Ulcer</condition>
  <arm_group>
    <arm_group_label>Intervention Group</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Endovenous ablation + iliac US +/- iliac stenting</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Control Group</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Endovenous ablation of Great Saphenous Vein</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Endovenous ablation + iliac US +/- iliac stenting</intervention_name>
    <description>Concomitant Ablation of the GSV with endovenous therapy with associated iliac vein interrogation and stenting if required</description>
    <arm_group_label>Intervention Group</arm_group_label>
    <other_name>Graduated Compression Stockings</other_name>
    <other_name>Iliac vein intravascular ultrasound</other_name>
    <other_name>Iliac vein stenting</other_name>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Endovenous ablation of Great Saphenous Vein</intervention_name>
    <description>Ablation of the Great Saphenous Vein and subsequent Graduated Compression</description>
    <arm_group_label>Control Group</arm_group_label>
    <other_name>Graduated Compression Stockings</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Consenting patients

          -  aged 18 and over

          -  ultrasound detected Great Saphenous Venous incompetence

          -  an associated primary or recurrent lower limb venous ulcer(s)

        Exclusion Criteria:

          -  Ankle-brachial pressure index &lt;0.8

          -  Previous inability to tolerate lower limb compression bandaging

          -  Inability to provide informed consent

          -  Previous lower limb arterial revascularisation procedure

          -  Contrast allergy

          -  Previous history of pelvic malignancy or pelvic radiotherapy

          -  Pregnancy

          -  Previous iliac vein intervention

          -  Previous superficial vein intervention

          -  Infection in previous 30 days

          -  Estimated glomerular filtration rate (eGFR) &lt; 60 mls/kg/min

          -  Isolated short saphenous or perforator vein reflux only

          -  Leg ulcer of non-venous aetiology (as assessed by clinician)

          -  Unfit for endovascular intervention based on history and examination

          -  Any compression therapy within six-months

          -  Evidence of deep venous incompetence/thrombosis
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>Soalta Hospital Group</name>
      <address>
        <city>Galway</city>
        <zip>0000</zip>
        <country>Ireland</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Thomas m Aherne, MBBCHBAO</last_name>
      <phone>091542000</phone>
      <email>thomasaherne@rcsi.com</email>
    </contact>
    <contact_backup>
      <last_name>Stewart R Walsh, MBBCHBAO</last_name>
    </contact_backup>
  </location>
  <location>
    <facility>
      <name>Univsersity Hospital Galway</name>
      <address>
        <city>Galway</city>
        <zip>0000</zip>
        <country>Ireland</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Thomas M Aherne, MBBChBAO, MCh</last_name>
      <phone>091542000</phone>
      <email>tommyaherne@hotmail.com</email>
    </contact>
  </location>
  <location_countries>
    <country>Ireland</country>
  </location_countries>
  <verification_date>February 2020</verification_date>
  <study_first_submitted>August 14, 2018</study_first_submitted>
  <study_first_submitted_qc>August 20, 2018</study_first_submitted_qc>
  <study_first_posted type="Actual">August 21, 2018</study_first_posted>
  <last_update_submitted>February 24, 2020</last_update_submitted>
  <last_update_submitted_qc>February 24, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">February 26, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>National University of Ireland, Galway, Ireland</investigator_affiliation>
    <investigator_full_name>Thomas Aherne</investigator_full_name>
    <investigator_title>Principle Investigator Dr Thomas Aherne</investigator_title>
  </responsible_party>
  <keyword>Venous ulcer</keyword>
  <keyword>Great saphenous incompetence</keyword>
  <keyword>Iliac vein</keyword>
  <keyword>Endovenous therapy</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Varicose Ulcer</mesh_term>
    <mesh_term>Leg Ulcer</mesh_term>
    <mesh_term>Ulcer</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>Yes</sharing_ipd>
    <ipd_info_type>Study Protocol</ipd_info_type>
    <ipd_info_type>Informed Consent Form (ICF)</ipd_info_type>
    <ipd_info_type>Clinical Study Report (CSR)</ipd_info_type>
    <ipd_time_frame>1 year for 5 years</ipd_time_frame>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

